2008
DOI: 10.1016/j.exger.2007.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Zinc supplementation for the treatment or prevention of disease: Current status and future perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
111
0
3

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 170 publications
(122 citation statements)
references
References 129 publications
0
111
0
3
Order By: Relevance
“…This is a common finding in diabetic patients and can be related to hyperzincuria (16). It is well established that zinc supplementation effectively prevents the metabolic syndrome and diabetes and its secondary complications (13,38). In our study, ZnO treatment to diabetic rats improved serum zinc status in a time-and dose-dependent manner.…”
Section: Discussionmentioning
confidence: 58%
See 1 more Smart Citation
“…This is a common finding in diabetic patients and can be related to hyperzincuria (16). It is well established that zinc supplementation effectively prevents the metabolic syndrome and diabetes and its secondary complications (13,38). In our study, ZnO treatment to diabetic rats improved serum zinc status in a time-and dose-dependent manner.…”
Section: Discussionmentioning
confidence: 58%
“…A wide range of biological activities such as cell division (8), immune responses regulation (9,10), epithelial cell integrity (11), and the proper function of more than 300 enzymes from all enzyme families (12,13) are tightly correlated with zinc.…”
Section: Introductionmentioning
confidence: 99%
“…7 Since, the role of Zinc in insulin synthesis and secretion has been established over the years, [18][19][20][21] it is possible that hypozincaemia caused by chronic Frusemide administration may lead to hyperglycemia in normal individuals and deteriorate the condition further in diabetics.…”
Section: Discussionmentioning
confidence: 99%
“…Findings from several epidemiologic studies, however, attain no consensus on the effectiveness of zinc against prostate cancer, partly because of differences in experimental design, amount of zinc administered and methods in determining plasma/serum zinc status (Haase et al, 2008). Several studies showed that there are either no beneficiary effects of zinc or there are no potential adverse effects of dietary zinc on prostate cancer risk (Andersson et al, 1996;Kolonel, 1996;Vlajinac et al, 1997;West et al, 1991).…”
Section: Epidemiologic Studiesmentioning
confidence: 99%